Kansas Forges A Path For C-19 Early Treatment! State Senate Chamber Mentioned The HCQ And Ivermectin!

The Kansas State Senate made a bold move for the early C-19 treatments, and they were more accessible to the general population.

In a letter to the healthcare providers, the Kansas Senate Chamber shared the directives for treatment protocols.

Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender

The failure to utilize FDA-approved medications will be considered wanton disregarded.

HB 2280 was passed in the Kansas State Senate By a 21-16 vote.

The Off Label Drug Bull would allow healthcare providers to dispense off-label drugs for C-19 treatment, including ivermectin and HCQ.

Check this out:


The Kansas State Senate is the leader in helping Americans in getting the same ease of accessibility o to afford treatments.

The Topeka-Capital Journal reported:

The Legislature didn’t act on four pandemic-inspired bills rewriting public health laws: SB 489, SB 541, HB 2280 and HB 2416. The Senate previously passed the bills, but the House hasn’t been receptive to taking up the issues.

The legislation to promote ivermectin and hydroxychloroquine as off-label drugs to treat COVID-19 has been the most controversial of the four public health bills. Hilderbrand tried to push for that bill, HB 2280, during a Friday evening health conference committee meeting. Rep. Brenda Landwehr, R-Wichita, said no.

“I thought we had settled on some potential new language, and then discovered yesterday that we had not,” Landwehr said. “At this stage that we’re at, we’re not willing to move on that with what you’re offering.”



Leave a Reply

Your email address will not be published.